Effectiveness of revascularisation for the ulcerated foot in patients with diabetes and peripheral artery disease: A systematic review.
diabetes
diabetic foot
endovascular treatment
foot ulcer
peripheral artery disease
revascularisation
Journal
Diabetes/metabolism research and reviews
ISSN: 1520-7560
Titre abrégé: Diabetes Metab Res Rev
Pays: England
ID NLM: 100883450
Informations de publication
Date de publication:
04 Aug 2023
04 Aug 2023
Historique:
received:
08
07
2023
accepted:
10
07
2023
medline:
4
8
2023
pubmed:
4
8
2023
entrez:
4
8
2023
Statut:
aheadofprint
Résumé
Peripheral artery disease (PAD) is associated with an increased likelihood of delayed or non-healing of a diabetes-related foot ulcer, gangrene, and amputation. The selection of the most effective surgical technique for revascularisation of the lower limb in this population is challenging and there is a lack of conclusive evidence to support the choice of intervention. This systematic review aimed to determine, in people with diabetes and tissue loss, if direct revascularisation is superior to indirect revascularisation and if endovascular revascularisation is superior to open revascularisation for the outcomes of wound healing, minor or major amputation, and adverse events including mortality. Title and abstract searches of Medline, Embase, PubMed, and EBSCO were conducted from 1980 to 30th November 2022. Cohort and case-control studies and randomised controlled trials reporting comparative outcomes of direct (angiosome) revascularisation (DR) and indirect revascularisation (IR) or the comparative outcomes of endovascular revascularisation and open or hybrid revascularisation for the outcomes of healing, minor amputation, and major amputation in people with diabetes, PAD and tissue loss (including foot ulcer and/or gangrene) were eligible. Methodological quality was assessed using the Cochrane risk-of-bias tool for randomised trials, the ROBINS-I tool for non-randomised studies, and Newcastle-Ottawa Scale for observational and cohort studies where details regarding the allocation to intervention groups were not provided. From a total 7086 abstracts retrieved, 26 studies met the inclusion criteria for the comparison of direct angiosome revascularisation (DR) and indirect revascularisation (IR), and 11 studies met the inclusion criteria for the comparison of endovascular and open revascularisation. One study was included in both comparisons. Of the included studies, 35 were observational (31 retrospective and 4 prospective cohorts) and 1 was a randomised controlled trial. Cohort study quality was variable and generally low, with common sources of bias related to heterogeneous participant populations and interventions and lack of reporting of or adjusting for confounding factors. The randomised controlled trial had a low risk of bias. For studies of DR and IR, results were variable, and it is uncertain if one technique is superior to the other for healing, prevention of minor or major amputation, or mortality. However, the majority of studies reported that a greater proportion of participants receiving DR healed compared with IR, and that IR with collaterals may have similar outcomes to DR for wound healing. For patients with diabetes, infrainguinal PAD, and an adequate great saphenous vein available for use as a bypass conduit who were deemed suitable for either surgical procedure, an open revascularisation first approach was superior to endovascular therapy to prevent a major adverse limb event or death (Hazard Ratio: 0.72; 95% CI 0.61-0.86). For other studies of open and endovascular approaches, there was generally no difference in outcomes between the interventions. The majority of available evidence for the effectiveness of DR and IR and open and endovascular revascularisation for wound healing and prevention of minor and major amputation and adverse events including mortality in people with diabetes, PAD and tissue loss is inconclusive, and the certainty of evidence is very low. Data from one high quality randomised controlled trial supports the use of open over endovascular revascularisation to prevent a major limb event and death in people with diabetes, infrainguinal disease and tissue loss who have an adequate great saphenous vein available and who are deemed suitable for either approach.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e3700Informations de copyright
© 2023 The Authors. Diabetes/Metabolism Research and Reviews published by John Wiley & Sons Ltd.
Références
Leibson CL, Ransom JE, Olson W, Zimmerman BR, O'Fallon WM, Palumbo PJ. Peripheral arterial disease, diabetes, and mortality. Diabetes Care. 2004;27(12):2843-2849. https://doi.org/10.2337/diacare.27.12.2843
Armstrong DG, Boulton AJ, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367-2375. https://doi.org/10.1056/nejmra1615439
Lepäntalo M, Mätzke S. Outcome of unreconstructed chronic critical leg ischaemia. Eur J Vasc Endovasc Surg. 1996;11(2):153-157. https://doi.org/10.1016/s1078-5884(96)80044-x
Elgzyri T, Larsson J, Nyberg P, Thörne J, Eriksson KF, Apelqvist J. Early revascularization after admittance to a diabetic foot center affects the healing probability of ischemic foot ulcer in patients with diabetes. Eur J Vasc Endovasc Surg. 2014;48(4):440-446. https://doi.org/10.1016/j.ejvs.2014.06.041
van Netten JJ, Baba M, Lazzarini PA. Epidemiology of diabetic foot disease and diabetes-related lower-extremity amputation in Australia: a systematic review protocol. Syst Rev. 2017;6(1):101. https://doi.org/10.1186/s13643-017-0488-5
Kurowski JR, Nedkoff L, Schoen DE, Knuiman M, Norman PE, Briffa TG. Temporal trends in initial and recurrent lower extremity amputations in people with and without diabetes in Western Australia from 2000 to 2010. Diabetes Res Clin Pract. 2015;108(2):280-287. https://doi.org/10.1016/j.diabres.2015.02.008
Taylor G, Palmer J. The vascular territories (angiosomes) of the body: experimental study and clinical applications. Br J Plast Surg. 1987;40(2):113-141. https://doi.org/10.1016/0007-1226(87)90185-8
Acín F, Varela C, López de Maturana I, de Haro J, Bleda S, Rodriguez-Padilla J. Results of infrapopliteal endovascular procedures performed in diabetic patients with critical limb ischemia and tissue loss from the perspective of an angiosome-oriented revascularization strategy. Int J Vasc Med. 2014;2014:270539. https://doi.org/10.1155/2014/270539
Alexandrescu V.-A, Brochier S, Limgba A, et al. Healing of diabetic neuroischemic foot wounds with vs without wound-targeted revascularization: preliminary observations from an 8-year prospective dual-center registry. J Endovasc Ther. 2020;27(1):20-30. https://doi.org/10.1177/1526602819885131
Bekeny JC, Alfawaz A, Day J, et al. Indirect endovascular revascularization via collaterals: a new classification to predict wound healing and limb salvage. Ann Vasc Surg. 2021;73:264-272. https://doi.org/10.1016/j.avsg.2020.11.031
Zheng XT, Zeng RC, Huang JY, et al. The use of the angiosome concept for treating infrapopliteal critical limb ischemia through interventional therapy and determining the clinical significance of collateral vessels. Ann Vasc Surg. 2016;32:41-49. https://doi.org/10.1016/j.avsg.2015.09.021
Alexandrescu V.-A, Hubermont G, Philips Y, et al. Selective primary angioplasty following an angiosome model of reperfusion in the treatment of Wagner 1-4 diabetic foot lesions: practice in a multidisciplinary diabetic limb service. J Endovasc Ther. 2008;15(5):580-593. https://doi.org/10.1583/08-2460.1
Azuma N, Uchida H, Kokubo T, Koya A, Akasaka N, Sasajima T. Factors influencing wound healing of critical ischaemic foot after bypass surgery: is the angiosome important in selecting bypass target artery? Eur J Vasc Endovasc Surg. 2012;43(3):322-328. https://doi.org/10.1016/j.jvs.2012.01.037
Rashid H, Slim H, Zayed H, et al. The impact of arterial pedal arch quality and angiosome revascularization on foot tissue loss healing and infrapopliteal bypass outcome. J Vasc Surg. 2013;57(5):1219-1226. https://doi.org/10.1016/j.jvs.2012.10.129
Kret MR, Cheng D, Azarbal AF, et al. Utility of direct angiosome revascularization and runoff scores in predicting outcomes in patients undergoing revascularization for critical limb ischemia. J Vasc Surg. 2014;59(1):121-128. https://doi.org/10.1016/j.jvs.2013.06.075
Aerden D, Denecker N, Gallala S, Debing E, Van den Brande P. Wound morphology and topography in the diabetic foot: hurdles in implementing angiosome-guided revascularization. Int J Vasc Med. 2014;2014:672897-672906. https://doi.org/10.1155/2014/672897
Jongsma H, Bekken JA, Akkersdijk GP, Hoeks SE, Verhagen HJ, Fioole B. Angiosome-directed revascularization in patients with critical limb ischemia. J Vasc Surg. 2017;65(4):1208-1219.e1. https://doi.org/10.1016/j.jvs.2016.10.100
Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2001;24(8):1433-1437. https://doi.org/10.2337/diacare.24.8.1433
Golledge J. Update on the pathophysiology and medical treatment of peripheral artery disease. Nat Rev Cardiol. 2022;19(7):456-474. https://doi.org/10.1038/s41569-021-00663-9
Low Wang CC, Blomster JI, Heizer G, et al. Cardiovascular and limb outcomes in patients with diabetes and peripheral artery disease: the EUCLID trial. J Am Coll Cardiol. 2018;72(25):3274-3284. https://doi.org/10.1016/j.jacc.2018.09.078
Bradbury AW, Ruckley C, Fowkes F, Forbes J, Gillespie I, Adam D. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366(9501):1925-1934.
Iida O, Takahara M, Soga Y, Kodama A, Terashi H, Azuma N. Three-year outcomes of surgical versus endovascular revascularization for critical limb ischemia: the SPINACH study (surgical reconstruction versus peripheral intervention in patients with critical limb ischemia). Circ Cardiovasc Interv. 2017;10(12):e005531. https://doi.org/10.1161/circinterventions.117.005531
Forsythe RO, Apelqvist J, Boyko EJ, et al. Effectiveness of revascularisation of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review. Diabetes Metab Res Rev. 2020;36(Suppl 1):e3279. https://doi.org/10.1002/dmrr.3279
Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg. 2019;58(1s):S1-S109.e33. https://doi.org/10.1016/j.jvs.2019.02.016
Kim KG, Meshkin DH, Tirrell AR, et al. A systematic review and meta-analysis of endovascular angiosomal revascularization in the setting of collateral vessels. J Vasc Surg. 2021;74(4):1406-1416.e3. https://doi.org/10.1016/j.jvs.2021.04.026
Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https://doi.org/10.1136/bmj.l4898
Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. https://doi.org/10.1136/bmj.i4919
Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses; 2000.
Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. Bmj. 2001;323(7308):334-336. https://doi.org/10.1136/bmj.323.7308.334
Williams DT, Harding KG, Price P. An evaluation of the efficacy of methods used in screening for lower-limb arterial disease in diabetes. Diabetes Care. 2005;28(9):2206-2210. https://doi.org/10.2337/diacare.28.9.2206
Kreider N, Remp T, Puntscher S, Koenig A, Siebert U, Stempfle HU. Comparison of endovascular infrapopliteal revascularization strategies based on the angiosome model in diabetic patients within critical limb ischemia. Eur Heart J. 2020;41((Suppl 2)Suppl):2382. https://doi.org/10.1093/ehjci/ehaa946.2382
Špillerová K, Settembre N, Biancari F, Albäck A, Venermo M. Angiosome targeted PTA is more important in endovascular revascularisation than in surgical revascularisation: analysis of 545 patients with ischaemic tissue lesions. Eur J Vasc Endovasc Surg. 2017;53(4):567-575. https://doi.org/10.1016/j.ejvs.2017.01.008
Alexandrescu V, Vincent G, Azdad K, et al. A reliable approach to diabetic neuroischemic foot wounds: below-the-knee angiosome-oriented angioplasty. J Endovasc Ther. 2011;18(3):376-387. https://doi.org/10.1583/10-3260.1
Ambler GK, Stimpson A, Wardle B, et al. Infrapopliteal angioplasty using a combined angiosomal reperfusion strategy. PLoS One. 2017;12(2):e0172023. https://doi.org/10.1371/journal.pone.0172023
Augusto R, Campos J, Coelho A, et al. The endorevolution - going further in endovascular techniques dedicated to neuroischemic diabetic foot. Eur J Vasc Endovasc Surg. 2019;58(6 (Suppl 3)):e814-e5. https://doi.org/10.1016/j.ejvs.2019.09.413
Cheun TJ, Jayakumar L, Sideman MJ, Pounds LC, Davies MG. Outcomes of isolated inframalleolar interventions for chronic limb-threatening ischemia in diabetic patients. J Vasc Surg. 2020;71(5):1644-1652.e2. https://doi.org/10.1016/j.jvs.2019.07.094
de Athayde Soares R, Matielo MF, Brochado Neto FC, et al. WIfI classification versus angiosome concept: a change in the infrapopliteal angioplasties paradigm. Ann Vasc Surg. 2021;71:338-345. https://doi.org/10.1016/j.avsg.2020.07.049
Fossaceca R, Guzzardi G, Cerini P, et al. Endovascular treatment of diabetic foot in a selected population of patients with below-the-knee disease: is the angiosome model effective? Cardiovasc Interv Radiol. 2013;36(3):637-644. https://doi.org/10.1007/s00270-012-0544-4
Hou X, Guo P, Cai F, Lin Y, Zhang J. Angiosome-Guided endovascular revascularization for treatment of diabetic foot ulcers with peripheral artery disease. Ann Vasc Surg. 2022;86:242-250. https://doi.org/10.1016/j.avsg.2022.02.012
Iacopi E, Coppelli A, Goretti C, et al. Effect of direct endovascular revascularization based on the angiosome model on risk of major amputations and life expectancy in type 2 diabetic patients with critical limb ischemia and foot ulceration. J Am Podiatr Med Assoc. 2021;111(4). https://doi.org/10.7547/18-130
Jeon EY, Cho YK, Yoon DY, Kim DJ, Woo JJ. Clinical outcome of angiosome-oriented infrapopliteal percutaneous transluminal angioplasty for isolated infrapopliteal lesions in patients with critical limb ischemia. Diagn Interv Radiol. 2016;22(1):52-58. https://doi.org/10.5152/dir.2015.15129
Ji D, Zhang T, Li C, Liu Y, Wang F. Evaluation of angiosome-targeted infrapopliteal endovascular revascularization in critical diabetic limb ischemia. J Interv Med. 2018;1(3):176-181.
Lejay A, Georg Y, Tartaglia E, et al. Long-term outcomes of direct and indirect below-the-knee open revascularization based on the angiosome concept in diabetic patients with critical limb ischemia. Ann Vasc Surg. 2014;28(4):983-989. https://doi.org/10.1016/j.avsg.2013.08.026
Lo ZJ, Lin Z, Pua U, et al. Diabetic foot limb salvage-a series of 809 attempts and predictors for endovascular limb salvage failure. Ann Vasc Surg. 2018;49:9-16. https://doi.org/10.1016/j.avsg.2018.01.061
Neville RF, Attinger CE, Bulan EJ, Ducic I, Thomassen M, Sidawy AN. Revascularization of a specific angiosome for limb salvage: does the target artery matter? Ann Vasc Surg. 2009;23(3):367-373. https://doi.org/10.1016/j.avsg.2008.08.022
Soderstrom M, Alback A, Biancari F, Lappalainen K, Lepantalo M, Venermo M. Angiosome-targeted infrapopliteal endovascular revascularization for treatment of diabetic foot ulcers. J Vasc Surg. 2013;57(2):427-435. https://doi.org/10.1016/j.jvs.2012.07.057
Weaver ML, Hicks CW, Canner JK, et al. The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system predicts wound healing better than direct angiosome perfusion in diabetic foot wounds. J Vasc Surg. 2018;68(5):1473-1481. https://doi.org/10.1016/j.jvs.2018.01.060
Del Carmen DTM, Mestre FXM, Rico CM, Coll RV. Comparison between primary minor amputations and minor amputations with previous revascularization in diabetic foot pathology. Angiologia. 2021;73(1):4-10.
Troisi N, Turini F, Chisci E, et al. Pedal arch patency and not direct-angiosome revascularization predicts outcomes of endovascular interventions in diabetic patients with critical limb ischemia. Int Angiol. 2017;36(5):438-444. https://doi.org/10.23736/s0392-9590.17.03809-3
Kabra A, Suresh KR, Vivekanand V, Vishnu M, Sumanth R, Nekkanti M. Outcomes of angiosome and non-angiosome targeted revascularization in critical lower limb ischemia. J Vasc Surg. 2013;57(1):44-49. https://doi.org/10.1016/j.jvs.2012.07.042
Khalefa S, Eldmarany H, El Bahaey A, Abdelmoneam M, Hindawy K. Comparison between direct and indirect revascularization of below-the-knee arterial occlusive diseases based on foot angiosome concept. Egypt J Surg. 2019;38(4):783-789.
Neville R. Pedal revascularization: extending the limits of endovascular or surgical means to prevent amputation. Vasc Dis Manage. 2019;16(6):1-5.
Cury MVM, Brochado Neto FC, Matielo MF, et al. Evaluation of the BASIL survival prediction model in patients undergoing infrapopliteal interventions for critical limb ischemia. Ann Vasc Surg. 2019;55:85-95. https://doi.org/10.1016/j.avsg.2018.06.007
Darling JD, O'Donnell TFX, Deery SE, et al. Outcomes after first-time lower extremity revascularization for chronic limb-threatening ischemia in insulin-dependent diabetic patients. J Vasc Surg. 2018;68(5):1455-1464.e1. https://doi.org/10.1016/j.jvs.2018.01.055
Deery SE, Hicks CW, Canner JK, Lum YW, Black JH, 3rd, Abularrage CJ. Patient-centered clinical success after lower extremity revascularization for complex diabetic foot wounds treated in a multidisciplinary setting. J Vasc Surg. 2022;75(4):1377-1384.e1. https://doi.org/10.1016/j.jvs.2021.11.063
Farber A, Menard MT, Conte MS, et al. Surgery or endovascular therapy for chronic limb-threatening ischemia. N Engl J Med. 2022;387(25):2305-2316. https://doi.org/10.1056/nejmoa2207899
Gomez-Sanchez C, Werlin E, Sorrentino T, et al. Open revascularization approach is associated with healing and ambulation after transmetatarsal amputation in patients with chronic limb threatening ischemia. J Vasc Surg. 2023;77(4):1147-1154.e3. https://doi.org/10.1016/j.jvs.2022.12.035
Gray WK, Day J, Horrocks M. Outcomes for angioplasty and bypass lower limb revascularisation procedures for limb salvage in England: findings from the getting it right first time programme. Eur J Vasc Endovasc Surg. 2020;60(5):711-719. https://doi.org/10.1016/j.jvs.2020.09.016
Hicks CW, Najafian A, Farber A, et al. Diabetes does not worsen outcomes following infrageniculate bypass or endovascular intervention for patients with critical limb ischemia. J Vasc Surg. 2016;64(6):1667-1674.e1. https://doi.org/10.1016/j.jvs.2016.07.107
Wolfle KD, Bruijnen H, Reeps C, et al. Tibioperoneal arterial lesions and critical foot ischaemia: successful management by the use of short vein grafts and percutaneous transluminal angioplasty. Vasa. 2000;29(3):207-214. https://doi.org/10.1024/0301-1526.29.3.207
Zhan LX, Trinidad-Hernandez M, Armstrong DG, Mills JL. Comparative effectiveness of endovascular and open surgical revascularization in diabetic patients with "critical limb ischemia" (Rutherford 5 and 6) due to severe tibial artery occlusive disease. J Vasc Surg. 2012;56(2):581. https://doi.org/10.1016/j.jvs.2012.05.025
Mohapatra A, Henry JC, Avgerinos ED, et al. Bypass versus endovascular intervention for healing ischemic foot wounds secondary to tibial arterial disease. J Vasc Surg. 2018;68(1):168-175. https://doi.org/10.1016/j.jvs.2017.10.076
Graziani L, Silvestro A, Bertone V, et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg. 2007;33(4):453-460. https://doi.org/10.1016/j.ejvs.2006.11.022
Mills JL, Sr., Conte MS, Armstrong DG, et al. The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014;59(1):220-234.e1-2. https://doi.org/10.1016/j.jvs.2013.08.003